12 research outputs found
A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit
Background: While studying the etiology of multiple sclerosis (MS) in children has several methodological advantages over studying etiology in adults, studies are limited by small sample sizes.
Objective: Using a rigorous methodological process, we developed the Pediatric MS Tool-Kit, a measurement framework that includes a minimal set of core variables to assess etiological risk factors.
Methods: We solicited input from the International Pediatric MS Study Group to select three risk factors: environmental tobacco smoke (ETS) exposure, sun exposure, and vitamin D intake. To develop the
Tool-Kit, we used a Delphi study involving a working group of epidemiologists, neurologists, and content
experts from North America and Europe.
Results: The Tool-Kit includes six core variables to measure ETS, six to measure sun exposure, and six
to measure vitamin D intake. The Tool-Kit can be accessed online (www.maelstrom-research.org/mica/
network/tool-kit).
Conclusion: The goals of the Tool-Kit are to enhance exposure measurement in newly designed pediatric
MS studies and comparability of results across studies, and in the longer term to facilitate harmonization
of studies, a methodological approach that can be used to circumvent issues of small sample sizes. We
believe the Tool-Kit will prove to be a valuable resource to guide pediatric MS researchers in developing
study-specific questionnaire
Совершенствование технологий для осуществления рентабельного процесса добычи нефти на малодебитном фонде скважин
Материалы XII Междунар. науч. конф. студентов, магистрантов, аспирантов и молодых ученых, Гомель, 16–17 мая 2019 г
Harmonising and linking biomedical and clinical data across disparate data archives to enable integrative cross-biobank research
A wealth of biospecimen samples are stored in modern globally distributed biobanks. Biomedical researchers worldwide need to be able to combine the available resources to improve the power of large-scale studies. A prerequisite for this effort is to be able to search and access phenotypic, clinical and other information about samples that are currently stored at biobanks in an integrated manner. However, privacy issues together with heterogeneous information systems and the lack of agreed-upon vocabularies have made specimen searching across multiple biobanks extremely challenging. We describe three case studies where we have linked samples and sample descriptions in order to facilitate global searching of available samples for research. The use cases include the ENGAGE (European Network for Genetic and Genomic Epidemiology) consortium comprising at least 39 cohorts, the SUMMIT (surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools) consortium and a pilot for data integration between a Swedish clinical health registry and a biobank. We used the Sample avAILability (SAIL) method for data linking: first, created harmonised variables and then annotated and made searchable information on the number of specimens available in individual biobanks for various phenotypic categories. By operating on this categorised availability data we sidestep many obstacles related to privacy that arise when handling real values and show that harmonised and annotated records about data availability across disparate biomedical archives provide a key methodological advance in pre-analysis exchange of information between biobanks, that is, during the project planning phase
Homoparentalités, transparentalités et manifestations de la diversité familiale
Ce numéro de la revue Enfances Familles Générations examine les obstacles juridiques ou médicaux auxquels sont confrontées les minorités sexuelles dans leur accès à la parenté et analyse tant les réticences des législateurs occidentaux à définir une parenté « hybride », à la fois sociale et biologique, que les représentations sociales dans le discours populaire et dans les pratiques des couples de même sexe. Il traite aussi des enjeux relatifs au bien-être des enfants et à leur épanouissement dans les cadres familiaux atypiques
Harmonising and linking biomedical and clinical data across disparate data archives to enable integrative cross-biobank research
A wealth of biospecimen samples are stored in modern globally distributed biobanks. Biomedical researchers worldwide need to be able to combine the available resources to improve the power of large-scale studies. A prerequisite for this effort is to be able to search and access phenotypic, clinical and other information about samples that are currently stored at biobanks in an integrated manner. However, privacy issues together with heterogeneous information systems and the lack of agreed-upon vocabularies have made specimen searching across multiple biobanks extremely challenging. We describe three case studies where we have linked samples and sample descriptions in order to facilitate global searching of available samples for research. The use cases include the ENGAGE (European Network for Genetic and Genomic Epidemiology) consortium comprising at least 39 cohorts, the SUMMIT (surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools) consortium and a pilot for data integration between a Swedish clinical health registry and a biobank. We used the Sample avAILability (SAIL) method for data linking: first, created harmonised variables and then annotated and made searchable information on the number of specimens available in individual biobanks for various phenotypic categories. By operating on this categorised availability data we sidestep many obstacles related to privacy that arise when handling real values and show that harmonised and annotated records about data availability across disparate biomedical archives provide a key methodological advance in pre-analysis exchange of information between biobanks, that is, during the project planning phase.De två första författarna delar förstaförfattarskapet.</p
Harmonising and linking biomedical and clinical data across disparate data archives to enable integrative cross-biobank research
A wealth of biospecimen samples are stored in modern globally distributed biobanks. Biomedical researchers worldwide need to
be able to combine the available resources to improve the power of large-scale studies. A prerequisite for this effort is to be able
to search and access phenotypic, clinical and other information about samples that are currently stored at biobanks in an
integrated manner. However, privacy issues together with heterogeneous information systems and the lack of agreed-upon
vocabularies have made specimen searching across multiple biobanks extremely challenging. We describe three case studies
where we have linked samples and sample descriptions in order to facilitate global searching of available samples for research.
The use cases include the ENGAGE (European Network for Genetic and Genomic Epidemiology) consortium comprising at least
39 cohorts, the SUMMIT (surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools)
consortium and a pilot for data integration between a Swedish clinical health registry and a biobank. We used the Sample
avAILability (SAIL) method for data linking: first, created harmonised variables and then annotated and made searchable
information on the number of specimens available in individual biobanks for various phenotypic categories. By operating on this
categorised availability data we sidestep many obstacles related to privacy that arise when handling real values and show that
harmonised and annotated records about data availability across disparate biomedical archives provide a key methodological
advance in pre-analysis exchange of information between biobanks, that is, during the project planning phase
Life course of retrospective harmonization initiatives:key elements to consider
Abstract
Optimizing research on the developmental origins of health and disease (DOHaD) involves implementing initiatives maximizing the use of the available cohort study data; achieving sufficient statistical power to support subgroup analysis; and using participant data presenting adequate follow-up and exposure heterogeneity. It also involves being able to undertake comparison, cross-validation, or replication across data sets. To answer these requirements, cohort study data need to be findable, accessible, interoperable, and reusable (FAIR), and more particularly, it often needs to be harmonized. Harmonization is required to achieve or improve comparability of the putatively equivalent measures collected by different studies on different individuals. Although the characteristics of the research initiatives generating and using harmonized data vary extensively, all are confronted by similar issues. Having to collate, understand, process, host, and co-analyze data from individual cohort studies is particularly challenging. The scientific success and timely management of projects can be facilitated by an ensemble of factors. The current document provides an overview of the ‘life course’ of research projects requiring harmonization of existing data and highlights key elements to be considered from the inception to the end of the project